Palogic Value Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Palogic Value Management's AMGN Position: Q3 2026 in Review
Palogic Value Management reduced its Amgen (AMGN) stake by 1.2% in Q3 2026, selling an estimated $37.9K and leaving 7,698 shares worth $3.24M. The position accounts for 1.09% of the portfolio, ranked #19.
Palogic Value Management first reported a position in AMGN in Q4 2022 and has held it in 16 quarters since. 3,227 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Palogic Value Management held 7,698 shares of Amgen worth $3.24M as of Q3 2026.
- Palogic Value Management sold 95 Amgen shares in Q3 2026, an estimated $37.9K.
- Amgen made up 1.09% of Palogic Value Management's portfolio in Q3 2026, its #19 holding.
- Palogic Value Management first reported a position in Amgen in Q4 2022 and has held it in 16 quarters since.
- 3,227 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Palogic Value Management's 13F filing for Q3 2026, filed 16 Nov 2026.